AI주식인사이트AI Stock Insight
B

에스디바이오센서

137310KOSPI

57.4 / 100

Reference Date: 2026-09-08

Financial Score22.5 / 40
News Sentiment18.9 / 25
Momentum6.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 6.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

SD Biosensor, established in 2010, specializes in in-vitro diagnostics, offering products such as STANDARD Q, STANDARD F, and STANDARD E, which are known for high sensitivity and specificity. These products are used for rapid testing of various diseases, including COVID-19, and hold significant market share globally. The in-vitro diagnostics industry plays a crucial role in disease prevention and public health, with stringent regulations in major countries.

Number of Employees

656people

Average Salary

67.1M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
0.32Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
-19.49Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
18.81Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.5 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲4.1% (2-year basis)

Operating Profit Growth Rate
2.5 / 3

Avg ▲14.2% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -13.0% (declining, 3yr)

Detailed News Sentiment

11 totalPositive 8Neutral 1Negative 2Average Sentiment Score 75.5

Detailed Momentum

52-week position1.0Point

Near 52w low (6%, downtrend)

Current 6,170Won52-week high 10,84052-week low 5,820
1-month return2.0Point

1m -6.37% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-08-20
  • Neutral반기보고서 (2026.06)2026-08-14
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-12